These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22510399)

  • 21. Prevalence of Coronary Artery Disease Risk Factors and Metabolic Syndrome in Children with Heart Disease.
    Ware AL; Young PC; Weng C; Presson AP; Minich LL; Menon SC
    Pediatr Cardiol; 2018 Feb; 39(2):261-267. PubMed ID: 29058030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
    Shioji K; Izuhara M; Mitsuoka H; Uegaito T; Matsuda M;
    Cardiovasc Ther; 2014 Jun; 32(3):97-104. PubMed ID: 24456217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of inherited atherogenic dyslipidemias in children.
    Guardamagna O; Cagliero P; Abello F
    Ther Apher Dial; 2013 Apr; 17(2):150-61. PubMed ID: 23551671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
    Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experts question recommendations for universal lipid screenings in children.
    Mitka M
    JAMA; 2012 Aug; 308(8):750-1. PubMed ID: 22910740
    [No Abstract]   [Full Text] [Related]  

  • 26. Will obesity increase the proportion of children and adolescents recommended for a statin?
    McCrindle BW; Tyrrell PN; Kavey RE
    Circulation; 2013 Nov; 128(19):2162-5. PubMed ID: 24190936
    [No Abstract]   [Full Text] [Related]  

  • 27. Characteristics of Children Referred to a Lipid Clinic Before and After the Universal Screening Guidelines.
    Selvaraj K; Olave-Pichon A; Benuck I; Ariza AJ; Binns HJ
    Clin Pediatr (Phila); 2019 Jun; 58(6):656-664. PubMed ID: 30854883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of lipid screening guidelines in children by primary pediatric providers.
    Dixon DB; Kornblum AP; Steffen LM; Zhou X; Steinberger J
    J Pediatr; 2014 Mar; 164(3):572-6. PubMed ID: 24252785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening all children for lipid disorders.
    Shulman ST
    Pediatr Ann; 2012 Jul; 41(7):260-1. PubMed ID: 22765033
    [No Abstract]   [Full Text] [Related]  

  • 30. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesterol limits lose their lustre.
    Ledford H
    Nature; 2013 Feb; 494(7438):410-1. PubMed ID: 23446392
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipid management in high risk coronary patients: how effective are we at secondary intervention?
    Zhu YY; Hayward PA; Hare DL; Stewart AG; Buxton BF
    Heart Lung Circ; 2012 Feb; 21(2):82-7. PubMed ID: 22153966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening and treatment of dyslipidemias in children and adolescents.
    Daniels SR
    Horm Res Paediatr; 2011; 76 Suppl 1():47-51. PubMed ID: 21778749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.
    Poussa H; Strandberg TE; Tikkanen I; Kauhanen P; Lepäntalo M
    Scand Cardiovasc J; 2007 Jun; 41(3):138-41. PubMed ID: 17487761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dyslipidemia.
    Kopin L; Lowenstein C
    Ann Intern Med; 2017 Dec; 167(11):ITC81-ITC96. PubMed ID: 29204622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study.
    Waheed S; Pollack S; Roth M; Reichek N; Guerci A; Cao JJ
    Atherosclerosis; 2016 Dec; 255():193-199. PubMed ID: 27693004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Only a minority of patients referred for elective coronary artery bypass surgery have risk factors diagnosed and treated according to established guidelines.
    Anderson RE; Brismar K; Ivert T
    Diab Vasc Dis Res; 2007 Jun; 4(2):112-6. PubMed ID: 17654444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force.
    Haney EM; Huffman LH; Bougatsos C; Freeman M; Steiner RD; Nelson HD
    Pediatrics; 2007 Jul; 120(1):e189-214. PubMed ID: 17606543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins and myocardial infarction: Type, dose, and administration time: Does it matter?
    Papageorgiou N; Zacharia E; Briasoulis A; Androulakis E; Tousoulis D
    Trends Cardiovasc Med; 2016 Jul; 26(5):433-41. PubMed ID: 26948202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving Universal Pediatric Lipid Screening.
    DeSantes K; Dodge A; Eickhoff J; Peterson AL
    J Pediatr; 2017 Sep; 188():87-90. PubMed ID: 28595766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.